Hua Medicine (Shanghai) Ltd. (HKG:2552)

Hua Medicine (Shanghai) Statistics

Total Valuation

HKG:2552 has a market cap or net worth of HKD 3.00 billion. The enterprise value is 2.18 billion.

Market Cap	3.00B
Enterprise Value	2.18B

Important Dates

The next estimated earnings date is Friday, March 27, 2026.

Earnings Date	Mar 27, 2026
Ex-Dividend Date	n/a

Share Statistics

HKG:2552 has 988.01 million shares outstanding. The number of shares has increased by 0.69% in one year.

Current Share Class	988.01M
Shares Outstanding	988.01M
Shares Change (YoY)	+0.69%
Shares Change (QoQ)	+1.02%
Owned by Insiders (%)	5.55%
Owned by Institutions (%)	2.63%
Float	568.40M

Valuation Ratios

The trailing PE ratio is 2.54 and the forward PE ratio is 3.38.

PE Ratio	2.54
Forward PE	3.38
PS Ratio	7.39
PB Ratio	2.59
P/TBV Ratio	2.65
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	1.85
EV / Sales	5.37
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.02

Financial Position

The company has a current ratio of 7.79, with a Debt / Equity ratio of 0.26.

Current Ratio	7.79
Quick Ratio	6.98
Debt / Equity	0.26
Debt / EBITDA	n/a
Debt / FCF	-0.96
Interest Coverage	-26.60

Financial Efficiency

Return on equity (ROE) is 209.75% and return on invested capital (ROIC) is -18.43%.

Return on Equity (ROE)	209.75%
Return on Assets (ROA)	-9.41%
Return on Invested Capital (ROIC)	-18.43%
Return on Capital Employed (ROCE)	-18.35%
Weighted Average Cost of Capital (WACC)	9.64%
Revenue Per Employee	1.43M
Profits Per Employee	4.14M
Employee Count	285
Asset Turnover	0.24
Inventory Turnover	1.59

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +98.69% in the last 52 weeks. The beta is 1.11, so HKG:2552's price volatility has been higher than the market average.

Beta (5Y)	1.11
52-Week Price Change	+98.69%
50-Day Moving Average	3.13
200-Day Moving Average	3.32
Relative Strength Index (RSI)	48.06
Average Volume (20 Days)	2,831,767

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2552 had revenue of HKD 406.16 million and earned 1.18 billion in profits. Earnings per share was 1.20.

Revenue	406.16M
Gross Profit	213.44M
Operating Income	-253.51M
Pretax Income	1.18B
Net Income	1.18B
EBITDA	-238.10M
EBIT	-253.51M
Earnings Per Share (EPS)	1.20

Balance Sheet

The company has 1.12 billion in cash and 297.01 million in debt, with a net cash position of 823.74 million or 0.83 per share.

Cash & Cash Equivalents	1.12B
Total Debt	297.01M
Net Cash	823.74M
Net Cash Per Share	0.83
Equity (Book Value)	1.16B
Book Value Per Share	1.18
Working Capital	1.19B

Cash Flow

In the last 12 months, operating cash flow was -302.00 million and capital expenditures -8.69 million, giving a free cash flow of -310.69 million.

Operating Cash Flow	-302.00M
Capital Expenditures	-8.69M
Free Cash Flow	-310.69M
FCF Per Share	-0.31

Margins

Gross margin is 52.55%, with operating and profit margins of -62.42% and 290.30%.

Gross Margin	52.55%
Operating Margin	-62.42%
Pretax Margin	290.30%
Profit Margin	290.30%
EBITDA Margin	-58.62%
EBIT Margin	-62.42%
FCF Margin	n/a

Dividends & Yields

HKG:2552 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.69%
Shareholder Yield	-0.69%
Earnings Yield	39.26%
FCF Yield	-10.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2552 has an Altman Z-Score of -1.79 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.79
Piotroski F-Score	4